Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,870
archived clinical trials in
Pain

Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Research Protocol Management Specialists
mi
from
Pittsburgh, PA
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Research Protocol Management Specialists
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Coastal Medical
mi
from
East Greenwich, RI
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Coastal Medical
mi
from
East Greenwich, RI
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Omega Medical Research
mi
from
Warwick, RI
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Omega Medical Research
mi
from
Warwick, RI
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Radiant Research
mi
from
Greer, SC
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Radiant Research
mi
from
Greer, SC
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Neurology and Pain Clinic, LLC
mi
from
Orangeburg, SC
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Neurology and Pain Clinic, LLC
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
University Diabetes and Endocrine Consultants
mi
from
Chattanooga, TN
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
University Diabetes and Endocrine Consultants
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Sarah Cannon Research Institute
mi
from
Jackson, TN
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Sarah Cannon Research Institute
mi
from
Jackson, TN
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
AM Diabetes & Endocrinology Center
mi
from
Memphis, TN
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
AM Diabetes & Endocrinology Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
ClinRX Research LLC
mi
from
Carrollton, TX
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
ClinRX Research LLC
mi
from
Carrollton, TX
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Baylor University Medical Center
mi
from
Dallas, TX
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
The Medical Group of Texas
mi
from
Fort Worth, TX
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
The Medical Group of Texas
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
ClinRx Research, LLC
mi
from
Richardson, TX
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
ClinRx Research, LLC
mi
from
Richardson, TX
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Paragon Research Center
mi
from
San Antonio, TX
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Paragon Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Cetero Research - San Antonio
mi
from
San Antonio, TX
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Cetero Research - San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
L. Craig Larsen and Clark C. Larsen
mi
from
Murray, UT
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
L. Craig Larsen and Clark C. Larsen
mi
from
Murray, UT
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Aspen Clinical Research, LLC
mi
from
Orem, UT
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Aspen Clinical Research, LLC
mi
from
Orem, UT
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Daniel B. Vine, MD
mi
from
Salt Lake City, UT
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Daniel B. Vine, MD
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Wasatch Clinical Research
mi
from
Salt Lake City, UT
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Wasatch Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
Neurological Associates, Incorporated
mi
from
Henrico, VA
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
Neurological Associates, Incorporated
mi
from
Henrico, VA
Click here to add this to my saved trials
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated:  12/31/1969
University of Calgary
mi
from
Calgary,
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
A PHASE 3B MULTICENTER, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL EFFICACY AND SAFETY STUDY OF PREGABALIN IN THE TREATMENT OF PATIENTS WITH INADEQUATELY TREATED PAINFUL DIABETIC PERIPHERAL NEUROPATHY
Status: Enrolling
Updated: 12/31/1969
University of Calgary
mi
from
Calgary,
Click here to add this to my saved trials
Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients.
Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients.
Status: Enrolling
Updated:  12/31/1969
MGH Center for Translational Pain Research
mi
from
Boston, MA
Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients.
Effect of Spinal Cord Stimulation on Pain Thresholds and Sensory Perception in Chronic Pain Patients.
Status: Enrolling
Updated: 12/31/1969
MGH Center for Translational Pain Research
mi
from
Boston, MA
Click here to add this to my saved trials
Study on the Effect of a Beta Blocker on Increased Sensitivity to Pain in Humans Caused by Opioids
Effect of Beta Blockade on Opioid-Induced Hyperalgesia in Humans
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Study on the Effect of a Beta Blocker on Increased Sensitivity to Pain in Humans Caused by Opioids
Effect of Beta Blockade on Opioid-Induced Hyperalgesia in Humans
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
NoesisPharma
mi
from
Phoenix, AZ
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
NoesisPharma
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Connecticut Clinical Trials LLC
mi
from
Cromwell, CT
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Connecticut Clinical Trials LLC
mi
from
Cromwell, CT
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Institute for Behavioral Medicine
mi
from
Smyrna, GA
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Institute for Behavioral Medicine
mi
from
Smyrna, GA
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Healthy Perspectives Innovative Mental Health Services, PL
mi
from
Nashua, NH
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Healthy Perspectives Innovative Mental Health Services, PL
mi
from
Nashua, NH
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Albuquerque Neurosciences
mi
from
Albuquerque, NM
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Albuquerque Neurosciences
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Bioscience Research, Llc
mi
from
Mount Kisco, NY
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati College of Medicine
mi
from
Cincinnati, OH
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati College of Medicine
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Neuropsychiatric Center
mi
from
Oklahoma City, OK
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Neuropsychiatric Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Altoona Center for Clinical Research
mi
from
Duncansville, PA
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Arthritis and Osteoporosis Center of South Texas
mi
from
San Antonio, TX
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Arthritis and Osteoporosis Center of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Bateman Horne Center of Excellence
mi
from
Salt Lake City, UT
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Bateman Horne Center of Excellence
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Loma Linda University School of Medicine
mi
from
Loma Linda, CA
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Loma Linda University School of Medicine
mi
from
Loma Linda, CA
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Synergy Clinical Research
mi
from
National City, CA
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Synergy Clinical Research
mi
from
National City, CA
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Associated Neurologists of Southern Connecticut, PC
mi
from
Fairfield, CT
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Associated Neurologists of Southern Connecticut, PC
mi
from
Fairfield, CT
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Riley Hosptial for Children
mi
from
Indianapolis, IN
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Riley Hosptial for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Richmond Behavorial Associates
mi
from
Staten Island, NY
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Richmond Behavorial Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Neurobehavioral Clinical Research
mi
from
Canton, OH
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Neurobehavioral Clinical Research
mi
from
Canton, OH
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
CRI Lifetree
mi
from
Philadelphia, PA
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
CRI Lifetree
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Holston Medical Group Clinical Research
mi
from
Kingsport, TN
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Holston Medical Group Clinical Research
mi
from
Kingsport, TN
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Advanced Pain Management
mi
from
Virginia Beach, VA
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Advanced Pain Management
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Palm Beach Research Center
mi
from
West Palm Beach, FL
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Palm Beach Research Center
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Kentucky Medical Research Center
mi
from
Lexington, KY
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Kentucky Medical Research Center
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
Mercy Health Research
mi
from
Saint Louis, MO
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Mercy Health Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
North Star Research
mi
from
Middleburg Heights, OH
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
North Star Research
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
NeuroScience, Inc.
mi
from
Herndon, VA
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
San Miguel de Tucuman,
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
San Miguel de Tucuman,
Click here to add this to my saved trials